Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001373047 | SCV001569747 | likely benign | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002550164 | SCV003749616 | uncertain significance | Inborn genetic diseases | 2022-04-13 | criteria provided, single submitter | clinical testing | The c.2503G>A (p.E835K) alteration is located in exon 19 (coding exon 19) of the COL7A1 gene. This alteration results from a G to A substitution at nucleotide position 2503, causing the glutamic acid (E) at amino acid position 835 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001826109 | SCV002079286 | uncertain significance | Epidermolysis bullosa dystrophica | 2020-05-06 | no assertion criteria provided | clinical testing |